NASDAQ : XRTX
XORTX Therapeutics Inc. — Financial statements
Healthcare · Biotechnology · Canada
Last price 1 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 1.82M
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Selling, General & Admin | 1.75M | 1.83M | 2.19M | 2.28M | 1.93M | 1.22M |
| Research & Development | 258.92K | 574.93K | 183.83K | 2.42M | 6.76M | 677.58K |
| Amortization of Goodwill & Intangibles | 20.17K | 26.39K | 31.07K | 66.63K | 17.08K | 14.27K |
| Operating Expenses | 2.13M | 2.54M | 2.62M | 4.96M | 9.24M | 2.31M |
| Operating Income | -2.13M | -2.54M | -2.62M | -4.96M | -9.24M | -2.31M |
| Interest Expense | -4.45K | |||||
| Interest & Investment Income | 15.44K | 41.87K | 121.91K | 253.54K | 103.59K | |
| Currency Exchange Gain (Loss) | -12.19K | -4.33K | -73.01K | -7.03K | -1.55K | -12.37K |
| Other Non Operating Income (Expenses) | -1.61M | -152.17K | -745.50K | 2.55M | 1.42M | 747.43K |
| EBT Excluding Unusual Items | -3.74M | -2.65M | -3.31M | -2.16M | -7.72M | -1.58M |
| Asset Writedown | -1.83K | -1.83K | ||||
| Pretax Income | -3.74M | -2.66M | -3.31M | -2.16M | -7.72M | -1.58M |
| Net Income | -3.74M | -2.66M | -3.31M | -2.16M | -7.72M | -1.58M |
| Net Income to Common | -3.74M | -2.66M | -3.31M | -2.16M | -7.72M | -1.58M |
| Shares Outstanding (Basic) | 1.32M | 946.93K | 575.70K | 396.35K | 295.98K | 218.84K |
| Shares Outstanding (Diluted) | 1.32M | 946.93K | 575.70K | 396.35K | 295.98K | 218.84K |
| EPS (Basic) | -2.83 | -2.81 | -5.76 | -5.44 | -26.08 | -7.22 |
| EPS (Diluted) | -2.83 | -2.81 | -5.76 | -5.45 | -26.10 | -7.22 |
| Free Cash Flow | -5.10M | -2.77M | -3.68M | -6.59M | -8.19M | -4.80M |
| Free Cash Flow Per Share | -3.85 | -2.92 | -6.39 | -16.62 | -27.66 | -21.94 |
| EBITDA | -2.15M | -2.51M | -2.58M | -4.82M | -9.22M | -2.30M |
| D&A For EBITDA | -14.80K | 31.35K | 38.75K | 139.69K | 19.95K | 14.27K |
| EBIT | -2.13M | -2.54M | -2.62M | -4.96M | -9.24M | -2.31M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 994.04K | 864.51K | 2.47M | 3.45M | 10.43M | 14.87M |
| Cash & Short-Term Investments | 994.04K | 864.51K | 2.47M | 3.45M | 10.43M | 14.87M |
| Other Receivables | 88.09K | 80.17K | 17.64K | 60.71K | 81.75K | 40.65K |
| Receivables | 88.09K | 80.17K | 17.64K | 60.71K | 81.75K | 40.65K |
| Prepaid Expenses | 1.35M | 22.61K | 184.25K | 236.97K | 379.62K | 438.45K |
| Other Current Assets | 293.80K | 1.17K | 323.44K | 563.77K | ||
| Total Current Assets | 2.44M | 1.26M | 2.68M | 4.07M | 10.90M | 15.91M |
| Property, Plant & Equipment | 37.06K | 34.72K | 23.93K | 92.68K | ||
| Other Intangible Assets | 2.55M | 185.37K | 183.11K | 175.25K | 199.83K | 202.12K |
| Other Long-Term Assets | 1.20M | 1.20M | 1.20M | 1.20M | 1.19M | 1.27M |
| Total Assets | 6.18M | 2.68M | 4.09M | 5.47M | 12.37M | 17.38M |
| Accounts Payable | 563.08K | 395.54K | 84.02K | 195.81K | 1.29M | 323.96K |
| Accrued Expenses | 115.45K | 158.25K | 63.19K | 87.61K | 151.41K | 228.99K |
| Current Portion of Leases | 37.29K | 38.78K | 11.51K | 66.09K | ||
| Other Current Liabilities | 1.00K | 8.00K | 572.00K | 531.00K | ||
| Total Current Liabilities | 679.52K | 599.07K | 757.99K | 825.94K | 1.51M | 552.95K |
| Long-Term Leases | 11.51K | |||||
| Other Long-Term Liabilities | 3.85M | 3.63M | ||||
| Total Liabilities | 679.52K | 599.07K | 757.99K | 825.94K | 5.38M | 4.18M |
| Common Stock | 20.80M | 20.18M | 18.49M | 17.06M | 16.52M | 16.09M |
| Retained Earnings | -26.32M | -23.82M | -21.17M | -17.85M | -15.70M | -7.98M |
| Comprehensive Income & Other | 11.02M | 5.73M | 6.01M | 5.44M | 6.17M | 5.09M |
| Shareholders' Equity | 5.50M | 2.08M | 3.34M | 4.64M | 7.00M | 13.20M |
| Total Liabilities & Equity | 6.18M | 2.68M | 4.09M | 5.47M | 12.37M | 17.38M |
| Total Debt | 37.29K | 38.78K | 11.51K | 77.60K | ||
| Net Cash (Debt) | 994.04K | 827.23K | 2.43M | 3.44M | 10.36M | 14.87M |
| Net Cash Per Share | 0.75 | 0.87 | 4.23 | 8.67 | 34.99 | 67.95 |
| Filing Date Shares Outstanding | 1.82M | 1.39M | 757.65K | 579.71K | 399.77K | 288.66K |
| Total Common Shares Outstanding | 1.73M | 1.39M | 696.27K | 399.77K | 334.01K | 288.66K |
| Working Capital | 1.76M | 662.03K | 1.92M | 3.24M | 9.38M | 15.36M |
| Book Value Per Share | 3.18 | 1.50 | 4.79 | 11.61 | 20.95 | 45.74 |
| Tangible Book Value | 2.96M | 1.90M | 3.15M | 4.47M | 6.80M | 13.00M |
| Tangible Book Value Per Share | 1.71 | 1.36 | 4.53 | 11.17 | 20.35 | 45.04 |
| Machinery | 23.34K | 23.34K | 23.34K | 23.34K | 19.03K |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -3.74M | -2.66M | -3.31M | -2.16M | -7.72M | -1.58M |
| Depreciation & Amortization | 102.66K | 112.11K | 117.27K | 139.69K | 58.15K | 14.27K |
| Asset Writedown & Restructuring Costs | 1.83K | 1.83K | ||||
| Stock-Based Compensation | 19.19K | 25.16K | 122.53K | 120.98K | 487.94K | 455.51K |
| Other Operating Activities | -164.41K | -587.74K | -721.90K | -3.66M | -2.47M | -2.61M |
| Change in Accounts Receivable | -77.23K | -62.53K | 43.07K | 21.04K | -41.10K | -29.38K |
| Change in Accounts Payable | 13.79K | 235.95K | -134.45K | -1.19M | 892.26K | -259.32K |
| Change in Other Net Operating Assets | -1.26M | 162.80K | 208.17K | 142.65K | 622.60K | -794.71K |
| Operating Cash Flow | -5.10M | -2.77M | -3.68M | -6.58M | -8.17M | -4.80M |
| Capital Expenditures | -4.31K | -19.70K | ||||
| Sale (Purchase) of Intangibles | -177.39K | -55.22K | -38.92K | -42.05K | -26.00K | -31.81K |
| Other Investing Activities | -239.73K | -239.73K | ||||
| Investing Cash Flow | -417.12K | -294.95K | -38.92K | -46.36K | -45.70K | -31.81K |
| Long-Term Debt Repaid | -89.57K | -69.72K | -66.09K | -20.41K | ||
| Lease Payments | -80.47K | -89.57K | -69.72K | -66.09K | -20.41K | |
| Net Debt Issued (Repaid) | -80.47K | -89.57K | -69.72K | -66.09K | -20.41K | |
| Issuance of Common Stock | 7.14M | 2.26M | 3.52M | 296.00 | 5.00M | 20.07M |
| Other Financing Activities | -1.61M | -738.43K | -667.88K | -295.25K | -1.07M | -698.58K |
| Financing Cash Flow | 5.46M | 1.43M | 2.78M | -361.04K | 3.91M | 19.37M |
| Foreign Exchange Rate Adjustments | -8.34K | 27.00K | -35.95K | 4.04K | -136.15K | 195.86K |
| Net Cash Flow | -69.43K | -1.61M | -974.02K | -6.99M | -4.44M | 14.74M |
| Free Cash Flow | -5.10M | -2.77M | -3.68M | -6.59M | -8.19M | -4.80M |
| Free Cash Flow Per Share | -3.85 | -2.92 | -6.39 | -16.62 | -27.66 | -21.94 |
| Levered Free Cash Flow | -2.58M | -1.86M | -1.11M | -3.67M | -3.80M | -826.21K |
| Unlevered Free Cash Flow | -2.58M | -1.86M | -1.11M | -3.67M | -3.80M | -823.43K |
| Free Cash Flow After Leases | -5.18M | -2.86M | -3.75M | -6.65M | -8.21M | -4.80M |
| Change in Working Capital | -1.32M | 336.22K | 116.79K | -1.03M | 1.47M | -1.08M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 1.83M | 3.91M | 3.93M | 4.62M | 11.63M | 26.63M |
| Enterprise Value | 840.69K | 2.78M | 1.69M | -423.39K | 2.86M | 22.68M |
| Last Close Price | 1.00 | 2.81 | 5.65 | 11.55 | 36.36 | 92.25 |
| PB Ratio | 0.31 | 1.88 | 1.18 | 0.99 | 1.66 | 2.02 |
| P/TBV Ratio | 0.61 | 2.06 | 1.25 | 1.03 | 1.71 | 2.05 |
| Debt / Equity Ratio | 0.02 | 0.01 | 0.00 | 0.01 | ||
| Net Debt / Equity Ratio | -0.18 | -0.40 | -0.73 | -0.74 | -1.48 | -1.13 |
| Net Debt / EBITDA Ratio | 0.46 | 0.33 | 0.94 | 0.71 | 1.12 | 6.48 |
| Net Debt / FCF Ratio | 0.20 | 0.30 | 0.66 | 0.52 | 1.26 | 3.10 |
| Quick Ratio | 1.59 | 1.58 | 3.29 | 4.25 | 6.96 | 26.96 |
| Current Ratio | 3.59 | 2.10 | 3.53 | 4.93 | 7.21 | 28.78 |
| Return on Equity (ROE) | -99.24% | -98.00% | -83.06% | -37.08% | -76.43% | -22.25% |
| Return on Assets (ROA) | -29.85% | -46.84% | -34.21% | -34.72% | -38.82% | -15.04% |
| Return on Capital Employed (ROCE) | -38.70% | -121.80% | -78.40% | -106.80% | -85.10% | -13.70% |
| Earnings Yield | -279.72% | -67.89% | -84.25% | -46.74% | -66.39% | -5.93% |
| FCF Yield | -280.78% | -70.76% | -93.54% | -142.67% | -70.40% | -18.03% |
| Buyback Yield / Dilution | -93.11% | -64.48% | -45.25% | -33.91% | -35.25% | -47.77% |